Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Cabozantinib and Radiation for Extremity Sarcoma
NCT04220229Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Jun 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in soft tissue sarcoma (STS), sponsored by University of Washington. Started Jun 2020; status: terminated.
02
Drugs
cabozantinib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04220229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220229.